Tae Mogami

No ORCID on file · 2 papers in corpus · active 2016-2021

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 2
other 2021
International journal of clinical oncology ·doi:10.1007/s10147-021-01914-y

BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI2) is a novel serum biomarker that discriminates ovarian clear cell carcinoma (CCC) from borderline ovarian tumors (BOTs) and non-clear cell epithelial ovarian cancers (EOCs). Here, we exam…

article 2016
International journal of clinical oncology ·doi:10.1007/s10147-016-1035-4